Catechins Market To Exceed Valuation Of US$ 30.5 Mn By 2032- FMI
May 04, 2022 08:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, May 04, 2022 (GLOBE NEWSWIRE) -- Total demand in the global catechins market is slated to surge at a 5.7% CAGR, reaching US$ 30.5 Mn by 2032. Catechins are extensively used in...
Plandai Biotechnology Discusses Cannabis Strategy, Research and Business
April 19, 2018 08:30 ET
|
Plandai Biotechnology, Inc.
LONDON, UNITED KINGDOM , April 19, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or “Plandai”), a producer of nutraceutical and highly phyto-available...
Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes
May 18, 2017 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced that it will conduct a human clinical trial to study the effectiveness of using its highly bioavailable...
Plandai Biotechnology's Production Facility Is an Intricate Maze of Proprietary Equipment Producing an Unmistakable Green Tea Extract
April 02, 2015 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - April 02, 2015) - After years of hard work, Plandaí Biotechnology (OTCQB: PLPL) has everything in place to start realizing the long-time dream of the company's CEO Roger...
Plandai Biotechnology Producing a More Potent Product Than First Reported
March 09, 2015 09:00 ET
|
Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - March 09, 2015) - Plandaí Biotechnology (OTCQB: PLPL) has probably chosen to err on the side of "under promise and over deliver" when it comes to the bioavailability of...